ASML NV Aktie
604,80EUR | 7,70EUR | 1,29% |
WKN DE: A1J4U4 / ISIN: NL0010273215
30.01.2025 11:21:30
ASML NV Buy
NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat die Einstufung für ASML nach Quartalszahlen auf "Buy" mit einem Kursziel von 1010 Euro belassen. Dies schrieb Analyst Alexander Duval in einer am Donnerstag vorliegenden Reaktion./edh/nas
Veröffentlichung der Original-Studie: 30.01.2025 / 07:53 / GMT
Erstmalige Weitergabe der Original-Studie: Datum in Studie nicht angegeben / Uhrzeit in Studie nicht angegeben / Zeitzone in Studie nicht angegeben
Hinweis: Informationen zur Offenlegungspflicht bei Interessenkonflikten im Sinne von § 85 Abs. 1 WpHG, Art. 20 VO (EU) 596/2014 für das genannte Analysten-Haus finden Sie unter http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
Zusammenfassung: ASML NV Buy | ||
---|---|---|
Unternehmen: ASML NV |
Analyst: Goldman Sachs Group Inc. |
Kursziel: 1 010,00 € |
Rating jetzt: Buy |
Kurs*: 709,20 € |
Abst. Kursziel*: 42,41% |
Rating update: Buy |
Kurs aktuell: 604,80 € |
Abst. Kursziel aktuell: 67,00% |
Analyst Name:: Alexander Duval |
KGV*: - |
* Zum Zeitpunkt der Analyse
Nachrichten zu ASML NVmehr Nachrichten
Analysen zu ASML NVmehr Analysen
12:50 | ASML NV Overweight | JP Morgan Chase & Co. | |
14.04.25 | ASML NV Overweight | JP Morgan Chase & Co. | |
08.04.25 | ASML NV Buy | Jefferies & Company Inc. | |
07.04.25 | ASML NV Overweight | JP Morgan Chase & Co. | |
07.04.25 | ASML NV Buy | Jefferies & Company Inc. |
Aktien in diesem Artikel
ASML NV | 604,80 | 1,29% |
|
Aktuelle Aktienanalysen
15:50 | Carl Zeiss Meditec Outperform | Bernstein Research | |
15:24 | L'Oréal Underweight | JP Morgan Chase & Co. | |
15:23 | L'Oréal Neutral | UBS AG | |
13:23 | Boeing Overweight | JP Morgan Chase & Co. | |
13:16 | Carl Zeiss Meditec Underweight | JP Morgan Chase & Co. | |
13:14 | Glencore Buy | UBS AG | |
13:13 | Rio Tinto Neutral | UBS AG | |
13:12 | Stellantis Hold | Deutsche Bank AG | |
13:11 | Vodafone Group Neutral | UBS AG | |
13:07 | DocMorris Hold | Deutsche Bank AG | |
13:04 | SAFRAN Buy | Deutsche Bank AG | |
12:55 | Netflix Outperform | Bernstein Research | |
12:55 | RATIONAL Reduce | Baader Bank | |
12:54 | Beiersdorf Outperform | Bernstein Research | |
12:54 | BNP Paribas Buy | Deutsche Bank AG | |
12:54 | Carl Zeiss Meditec Sector Perform | RBC Capital Markets | |
12:53 | TotalEnergies Outperform | RBC Capital Markets | |
12:52 | Sanofi Neutral | JP Morgan Chase & Co. | |
12:51 | Intel Underweight | JP Morgan Chase & Co. | |
12:50 | STMicroelectronics Neutral | JP Morgan Chase & Co. | |
12:50 | Infineon Neutral | JP Morgan Chase & Co. | |
12:50 | ASML NV Overweight | JP Morgan Chase & Co. | |
12:49 | National Grid Overweight | JP Morgan Chase & Co. | |
12:40 | Beiersdorf Sell | Deutsche Bank AG | |
12:36 | Beiersdorf Sector Perform | RBC Capital Markets | |
12:35 | Microsoft Buy | Jefferies & Company Inc. | |
12:34 | Alphabet A Buy | Jefferies & Company Inc. | |
12:34 | Netflix Buy | Jefferies & Company Inc. | |
12:33 | Amazon Buy | Jefferies & Company Inc. | |
12:33 | TotalEnergies Hold | Jefferies & Company Inc. | |
12:33 | ArcelorMittal Hold | Jefferies & Company Inc. | |
12:32 | National Grid Buy | Jefferies & Company Inc. | |
12:32 | Iberdrola Buy | Jefferies & Company Inc. | |
12:31 | RWE Buy | Jefferies & Company Inc. | |
12:31 | Enel Buy | Jefferies & Company Inc. | |
12:30 | E.ON Hold | Jefferies & Company Inc. | |
12:25 | SAF-HOLLAND Hold | Deutsche Bank AG | |
12:22 | National Grid Buy | UBS AG | |
12:22 | Iberdrola Buy | UBS AG | |
12:21 | E.ON Buy | UBS AG | |
12:20 | TotalEnergies Buy | UBS AG | |
12:19 | Ericsson Sell | UBS AG | |
12:19 | Beiersdorf Sell | UBS AG | |
12:17 | K+S Underperform | Jefferies & Company Inc. | |
12:17 | JOST Werke Buy | Deutsche Bank AG | |
12:15 | Beiersdorf Buy | Jefferies & Company Inc. | |
12:15 | LVMH Moet Hennessy Louis Vuitton Hold | Jefferies & Company Inc. | |
10:36 | London Stock Exchange Buy | Deutsche Bank AG | |
10:35 | LVMH Moet Hennessy Louis Vuitton Hold | Deutsche Bank AG | |
10:28 | LANXESS Buy | Warburg Research |